Limitations of diagnostic tests for bacterial infections.
Cross-reactions
Lyme disease
Maladie de Lyme
PCR
Réactions croisées
Serology
Sérologie
Journal
Medecine et maladies infectieuses
ISSN: 1769-6690
Titre abrégé: Med Mal Infect
Pays: France
ID NLM: 0311416
Informations de publication
Date de publication:
Mar 2019
Mar 2019
Historique:
received:
24
05
2018
accepted:
19
12
2018
pubmed:
29
1
2019
medline:
16
10
2019
entrez:
29
1
2019
Statut:
ppublish
Résumé
Lyme disease diagnosis is currently based on serology - an indirect diagnostic method - as laboratory cultures are fastidious. The only direct diagnostic method that can be useful with some specimens (cutaneous biopsies or aspiration fluid) is PCR. We aimed to detail the main limitations of serology and PCR testing in the diagnosis of bacterial infections. Limitations are supported by examples from the recent history of microbiology. The main limitation of bacterial serology is the presence of numerous cross-reactions due to many genes that are common to various bacterial species. Some serological techniques, such as those used for the diagnosis of rickettsioses mainly, have even been based on the existence of cross-reactions. The main limitation of PCR testing is the potential presence of laboratory contaminations. PCR-performing laboratories must therefore be certified for the use of this technique. PCR testing also does not inform on the viability of the identified bacterium and should therefore be interpreted in light of the clinical presentation. These limitations highlight that all diagnostic test results should not be interpreted on their own; the clinical and epidemiological contexts should always be taken into consideration.
Identifiants
pubmed: 30686500
pii: S0399-077X(18)30678-4
doi: 10.1016/j.medmal.2018.12.004
pii:
doi:
Substances chimiques
Antigens, Bacterial
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
98-101Informations de copyright
Copyright © 2019 The Authors. Published by Elsevier Masson SAS.. All rights reserved.